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Abstract (170 word max)
Normal neurovascular coupling, mediated by the fine interplay and communication of cells within the neurovascular unit, is critical for maintaining normal brain activity and cognitive function. This study investigated whether, with advancing age there is disruption of neurovascular coupling and specific cellular components of the neurovascular unit, and whether the effects of increasing amyloid (a key feature of Alzheimer’s disease) would exacerbate these changes. Transgenic APP mice (TgSwDI), in which age-dependent increases in amyloid are observed were compared to wild-type littermates in which amyloid is absent.   Neurovascular coupling was progressively impaired with increasing age (starting at 12months) but was not further altered in TgSwDI mice. Aged mice displayed significant reductions in astrocytic end-feet expression of aquaporin-4 on blood vessels compared to young mice, which correlated with neurovascular function. Aged mice also showed reduced vascular pericyte coverage and increased microglial proliferation relative to young. Strategies aimed to restore the loss of astrocytic end feet contact and neurovascular coupling may be useful in the prevention of cognitive decline and dementia.
Keywords (max 6, American spelling, no abbreviations)
Aging, Alzheimer, amyloid, neurovascular coupling, aquaporin
1.	Introduction (should be roughly a page in tnr 12 1.5 spacing)
(Subheadings)
The neurovascular unit is a dynamic multicellular structure comprised of cerebral blood vessels, endothelial cells, astrocytes and end-feet contacts on vessels, pericytes, neurons and microglia. The neurovascular unit serves critical roles and is responsible for formation and maintenance of the blood-brain barrier, controlling the exchange of substances between blood and brain and immune surveillance (Pober and Sessa, 2014). Critically, the efficient communication between the cells within the neurovascular unit, known as neurovascular coupling, ensures that cerebral vessel diameter is finely tuned to neuronal activity to maintain cerebral perfusion and meet metabolic demands. Astrocytes, which contact synapses and also vasculature via their endfeet processes, are ideally located to mediate neurovascular coupling, facilitated by astrocytic calcium signalling and release of vasoactive substances from the endfoot terminus (for review see Bazargani and Attwell, 2016). Pericytes, contractile cells that ensheathe capillary endothelial cells, have also been suggested to regulate blood flow in capillaries and may irreversibly constrict vessels following ischaemic insult (Hall et al. 2014). Impairment in neurovascular coupling or inability of the vasculature to respond to neuronal energy demands could result in neuronal metabolic stress and lead to cellular dysfunction and ultimately cognitive decline. 
Ageing, one of the most significant risk factors for development of dementia, has been shown to disrupt neurovascular coupling and to alter components of the neurovascular unit. Impairments in neurovascular coupling in mice have been shown to occur as early as 8 months (Balbi et al. 2015) and also at 12 months (Park et al. 2007). In human brain, the fMRI BOLD response has been used to demonstrate progressive impairments in neurovascular coupling with increasing age (Hutchison et al. 2013; Gauthier et al. 2013). Neuropathological studies have also highlighted structural alterations in the neurovascular unit with increasing age, including a reduction in pericyte number, reduced capillary density and vascular basement membrane thickening (Soto et al. 2015; Brown and Thore, 2011).
Amyloid, one of the key pathological hallmarks of Alzheimer’s disease, has also been shown to impair neurovascular coupling. Several transgenic mouse lines that express human amyloid precursor protein (APP) display reduced vascular responses to neuronal activity (Park et al. 2008 and 2014; Lourenco et al. 2015), an impairment thought to be mediated by reactive oxygen species (Hamel, 2015). Neurovascular coupling is also impaired in carriers of the APOE e4 allele (Fleisher et al. 2009), a major risk factor for development of Alzheimer’s disease that is thought to impair clearance of amyloid from the brain. In these individuals neurovascular dysfunction occurs prior to the onset of cognitive decline (Fleisher et al. 2009), indicating the potential as a modifiable target for therapeutics. Accumulation of amyloid both in vessels and parenchyma of human brain and in animal models is also associated with structural alterations in the neurovascular unit, notably alterations in vessel morphology, pericyte loss and vascular smooth muscle disruption (Park et al. 2014; Kalaria, 1997).
Despite evidence that neurovascular coupling becomes disrupted with ageing and in Alzheimer’s disease, the specific cell types that underlie these changes are still unknown. To address this, the present study sought to perform a comprehensive characterisation of the cells within the neurovascular unit and the extent of neurovascular coupling in TgAPP SwDI mice which develop age-related amyloid accumulation and compare these changes in the absence of amyloid in wild-type littermate controls at different ages. Astrocytes and their end feet contacts and pericytes are reported to regulate cerebral blood flow and thus it was hypothesised that reduced pericyte and astrocytic end–feet coverage of vessels would be related to impaired neurovascular coupling and that these changes would be heightened in the presence of amyloid. Although we found that neurovascular coupling was profoundly impaired with age this was not, as predicted, further exacerbated in the presence of amyloid. Loss of astrocytic end feet contacts were closely linked to these age-related alterations in neurovascular coupling. Although there was a loss of pericytes these were not associated with impaired coupling and instead glial proliferation was most closely linked to these functional impairments in coupling.

2. Methods
2.1 Animals:
Male C57Bl/6J and TgSwDI mice were studied at three age points: 6 months (n=7 C57Bl/6J, n=7 TgSwDI), 12 months (n=7 C57Bl/6J, n=5 TgSwDI) and 24 months (n=7 C57Bl/6J, n=9 TgSwDI). (Details of TgSwDI mouse phenotype/amyloid deposition etc need to go in) Unless otherwise stated, animals were group housed on a 12:12hr light/dark cycle and had access to food and water ad libitum. All experiments were conducted in accordance with the Animals (Scientific Procedures) Act 1986 and local ethical approval at the University of Edinburgh and were performed under personal and project licenses granted by the Home Office. All data collection and analysis was performed by experimenters blind to the age and genetic status of the mice.
2.2 Magnetic resonance imaging:
Mice were initially anaesthetised with 5% isoflurane in 100% oxygen and then anaesthesia was maintained with approx 1.5% isofluorane. The right femoral vein was cannulated for administration of the iron oxide contrast agent ferumoxytol for use in Q-map imaging. Mice were then placed in an MRI compatible holder (Rapid Biomedical, Wurzburg, Germany). Rectal temperature and respiration were monitored throughout (SA Instruments Inc., NY, US) and maintained within normal physiological parameters. Structural T2-weighted, arterial spin labelling (ASL), R2, R2* and DT-MRI data were collected using a Agilent 7T preclinical scanner (Agilent Technologies, Yarnton, UK); equipped with a high-performance gradient insert (120 mm inner diameter, maximum gradient strength 400 mT/m) and using a 72 mm quadrature volume coil and a phased array mouse brain coil (Rapid Biomedical GmbH, Rimpar, Germany). ASL was performed using a Look-Locker FAIR single gradient echo (LLFAIRGE) sequence (Kober et al. 2004; 2008) covering a 1.5mm thick brain slice corresponding to Figure 46 in the Mouse Brain Atlas (Paxinos and Franklin, 2001). Forty single phase-encoded gradient echoes spaced 200ms apart were acquired after a slice-selective or global adiabatic inversion pulse in an interleaved fashion resulting in an observation time of 8s. The flip angle was 20˚. The first 20˚pulse occurred 3ms after the inversion pulse. The echo time was 1.42ms. Q-map imaging was performed based on methods published by Boehm-Sturm et al (2013). The protocol consisted of R2 and R2* weighted scans performed before and 2 minutes after the intravenous injection of the iron oxide contrast agent ferumoxytol (30μl at 30mg Fe/kg). Diffusion tensor (DT)-MRI was also performed to measure and account for water diffusion in the tissue. R2 was acquired with a multi echo multi slice (MEMS) sequence (repetition time 2700ms; 16 echoes; 16 slices at 0.8mm; FOV 19.2x19.2mm; matrix size 128x128 and 4 signal averages) and R2* was acquired using a multi-echo multi slice gradient echo (MGEMS) sequence (repetition time 1000ms; 16 echoes; 16 slices at 0.8mm; FOV 19.2x19.2mm; matrix size 128x128; 4 signal averages; flip angle of 20˚). The DTI protocol consisted of 10 T2-weighted volumes without the diffusion gradients applied and sets of diffusion-weighted (b = 1000 s/mm2) volumes acquired with diffusion gradients (amplitude 14.33 G/cm, duration 5 ms, separation 26 ms) applied in 60 non-colinear directions, giving a total of 70 volumes (Jones et al., 1999). Sixteen slice locations identical to those used in the T2-weighted scan were imaged with a FOV of 19.2x19.2mm and an acquisition matrix of 96x96, with a TR and TE of 2000ms and 36ms respectively.
2.3 Magnetic resonance imaging analysis:
Relative CBF maps were constructed from ASL data in Matlab using in-house scripts. CBF maps were analysed in ImageJ (v1.46, NIH, Bethesda, MD, USA) using cortical regions of interest selected from T1 maps acquired with the ASL sequence. Q-maps were generated using Matlab and Statistical Parametric Mapping 8 software (SPM8, http://www.fil.ion.ucl.ac.uk/spm/software/spm8/ (​http:​/​​/​www.fil.ion.ucl.ac.uk​/​spm​/​software​/​spm8​/​​), Wellcome Trust Centre for Neuroimaging) and were analysed in ImageJ. Cortical and thalamic regions of interest were selected from T2-weighted structural scans.
2.4 Laser speckle imaging:
After MRI, mice were anaesthetised by intraperitoneal injection with alpha-chloralose (50mg/kg) and urethane (750mg/kg). The left whiskers were cut and the right whiskers, to be stimulated, trimmed to 1cm. Body temperature was monitored throughout the experiment using a rectal probe and modulated using a heat blanket. Mice were placed in a stereotaxic frame and ventilated via a nose cone with 100% oxygen at a rate of 150 breaths per minute. The head was fixed in place using ear and tooth bars and an incision was made over the midline. The scalp was retracted, the skull was cleaned of fur and a thin layer of ultrasound gel applied to prevent the skull drying. Stable baseline blood flow in the barrel cortex was recorded for 2 minutes using a laser speckle contrast imager (Moor FLPI2 Speckle Contrast Imager, Moor Instruments, UK). The whiskers were then deflected back and forth for 30 seconds in order to stimulate blood flow to the barrel cortex. Blood flow was allowed to return to a stable baseline before beginning the next stimulation. Speckle contrast images were analysed using MoorFLPI-2 Review software (version 4.0). Peak response amplitude was recorded during stimulation, and this was expressed as % increase from baseline to give a measure of vascular responsiveness. Results were averaged from 3 stimulations.

2.5 Tissue processing:
Mice were perfused with 20mls phosphate-buffered saline, whole brains were removed and fixed in 4% paraformaldehyde for 48hr and processed for paraffin embedding. 6µm coronal sections were collected corresponding to Fig 46. in stereotaxic mouse atlas (Paxinos and Franklin, 2001).
2.6 Immunohistochemistry:
Immunostaining was performed according to standard laboratory procedures. Sections were deparaffinised and endogenous peroxidase was quenched prior to antigen retrieval. Sections were blocked with 10% normal serum prior to incubation with primary antibodies overnight at 4°C. Biotinylated secondary antibodies were added for 1 hour, followed by amplification using a Vector ABC Elite Kit (Vector Labs, UK). Finally, peroxidase activity was visualised using 3,3’ diaminobenzadine tetrahydrochloride (DAB, Vector Labs, UK). For immunofluorescence, sections were deparaffinised prior to antigen retrieval, blocked with 10% normal serum and incubated with primary antibodies overnight at 4°C. AQP4 immunofluorescence was amplified using a biotinylated secondary. Sections were then incubated with AlexaFluor-conjugated secondary antibodies for 1 hour at room temperature and counterstained with DAPI. Primary antibodies were as follows: 6E10 mouse monoclonal Covance SIG-39320, 1:10,000 DAB and 1:750 immunofluorescence; ColIV goat polyclonal Millipore AB769, 1:100; GFAP rat monoclonal Life-Tech 13-0300, 1:100; AQP4 rabbit polyclonal Millipore AB3594, 1:500; PDGFR-β goat polyclonal R&D Systems AF1042, 1:200; Iba1 rabbit polyclonal Menarini MP-290 1:1000. Images of DAB stained sections were captured on a light microscope (x100, _______); immunofluorescence images were acquired using a laser scanning confocal microscope (x200, Zeiss 780, Carl Zeiss Microscopy, Cambridge, UK). All images were analysed using ImageJ software (v1.46, NIH, Bethesda, MD, USA). Percentage area stained by 6E10, ColIV, Iba1 and p47 was used to calculate total amyloid load, vessel density, microglial density and p47 density respectively. GFAP-positive astrocytes were manually counted. For quantification of vascular amyloid load, vascular AQP4 coverage and vascular PDGFR-β coverage, colocalisation between ColIV and either 6E10, AQP4 or PDGFR-β was calculated using Mander’s coefficient. Analysis was performed in 2-6 images per region per animal.
Statistical analysis: Laser speckle imaging measures of vascular function and MRI measures of resting cerebral blood flow and vessel density were analysed by two way ANOVA with age and genotype as the factors. The percentage area stained by 6E10, collagen IV, Iba1 and p47, as well as Mander’s coefficient of colocalisation between aquaporin-4, PDGFR-β and collagen IV, were compared using two-way ANOVA with age and genotype as the factors. Correlational analysis was performed using Spearman rank-order. All statistical analysis was performed using Prism GraphPad software (v5, GraphPad Software Inc, La Jolla, USA) and with p<0.05.

3. Results
3.1 TgSwDI mice exhibit parenchymal and vascular amyloid deposition which is absent in wild-type mice
Amyloid deposition is thought to contribute to cerebrovascular dysfunction. In order to quantify the extent of amyloid deposition in the cortex of TgSwDI and wild-type mice, 6E10 immunohistochemistry was performed at 6months and 24 months of age (Fig 1).  At 6months of age, amyloid was not detectable in TgSwDI or wild-type mice. However at 24months, there was a marked accumulation of amyloid in the cortex of TgSwDI mice and as expected amyloid was not present in age-matched wild-type littermate controls.  Overall, there was a significant effect of age and genotype (F(1,29)= 26.13, p< 0.0001 and F(1,29)= 67.32, p< 0.0001 respectively) and a significant interaction effect (F(1,29)= 24.95, p< 0.0001). These differences were due to a significant increase in amyloid in 24month old TgSwDI mice compared with 24 month wild type mice in which amyloid was not present (p<0.001). Previously it has been shown that vascular amyloid has a pronounced effect on neurovascular coupling (Han et al. 2008). Thus, to determine the extent of vascular amyloid in TgSwDI mice, the co-localisation of amyloid to collagen IV-labelled vessels was examined in the barrel cortex, the region in which neurovascular coupling was measured and the extent of parenchymal amyloid (i.e. amyloid outside vessels) also determined (Fig 1).  The coverage of vascular amyloid was found to be low albeit the extent of vascular amyloid significantly increased from 0.02 ± 0.025 to 0.06 ± 0.054 %? in 6 month and 24 month TgSwDI mice respectively (p<0.05). The percentage of cortical vessels which were found to have vascular amyloid also significantly increased with age, from 1.3% ± 2.5 to 2.7% ± 2.4 for 6 month vs 24 month old mice respectively (p<0.05). The extent of parenchymal amyloid was overall much higher than vascular amyloid in the TgSwDI mice at all ages. The percentage area of parenchymal amyloid staining significantly increased from 0.19 ± 0.11 % to 3.55 ± 0.72 % in 6 and 24 month TgSwDI mice respectively (p<0.05).
In TgSwDI mice, amyloid deposition is particularly prominent in the thalamus (Davis et al. 2004) and thus the extent of thalamic amyloid deposition was assessed in this brain region in TgSwDI mice and compared to wild-types (Supplementary Fig 1). There were significant effects of age and genotype (F(1,29)= 294.5, p< 0.0001 and F(1,29)= 300.4, p< 0.0001 respectively) and a significant interaction effect (F(1,29)= 290.7, p< 0.0001).  Amyloid deposition was significantly increased in 24 month old TgSwDI mice compared with 24 month wild type mice (p<0.001) whereas there was no significant difference at 6 months of age (p>0.05). Consistent with previous studies (Davis et al. 2004), the extent of vascular amyloid was found to be higher in the thalamus than in the cortex. Vascular amyloid also significantly increased from 0.003% ±0.005 to 0.65% ±0.19 (p<0.001) from 6 months of age to 24months of age in TgSwDI mice. The proportion of vessels covered by amyloid also increased significantly from 0.13% ± 0.27 to 28.6% ± 5.7 for 6 month vs 24 month old mice respectively (p<0.001). Again parenchymal amyloid load was higher than vascular load in the thalamus. The percentage area of parenchymal amyloid significantly increased from 0.1% ± 0.2 to 9.4% ± 2.8 between 6 and 24 months (p<0.001). 

3.2 Cortical resting cerebral blood flow is unchanged in wild-type and TgSwDI mice
In order to investigate whether ageing or amyloid deposition might affect baseline blood flow, arterial spin labelling was used to compare resting cerebral blood flow (rCBF) between groups. No significant differences in cortical blood flow were detected (p>0.05) (Fig 2). In the thalamus there were no significant effects of age or genotype, however there was a significant interaction effect (F(1,29)= 5.436, p<0.05) (Supplementary Fig 2).

3.3 Cortical vascular density is unchanged in wild-type and TgSwDI mice.
In order to determine if ageing or amyloid deposition would induce alterations in cerebral blood vessels, vascular density was assessed using both in vivo MRI and ex vivo immunohistochemical techniques. Q-map imaging was used to measure perfused vessel density in vivo, and collagen IV immunohistochemistry was used to measure vessel density in tissue slices. No significant differences in cortical vascular density were observed between groups with either Q-map imaging (p>0.05) or immunostochemical measures (p>0.05) (Fig 3).
In the thalamus, collagen IV immunohistochemistry analysis revealed significant effects of age and genotype (F(1,29)= 4.416, p<0.05 and F(1,29)= 7.917, p<0.01 respectively) (Supplementary Fig 3), however, no differences in vessel density were detected using in vivo Q-map imaging (p<0.05).

3.4 CBF increases to whisker stimulation are significantly attenuated in aged wild-type and TgSwDI mice.
Laser speckle imaging was used to measure the vasodilatory response to whisker stimulation in the barrel cortex. Neurovascular coupling was significantly impaired in aged wild type and TgSwDI mice relative to young (Fig 4). We found a significant effect of age (F(2,38)= 14.6, p< 0.001) however there was no significant effect of genotype (p>0.05).

3.5 Reduced pericyte coverage of cortical blood vessels in aged mice
Pericytes have been suggested to regulate cortical blood flow in capillaries (Hall et al. 2014), therefore we sought to determine whether changes in vascular pericyte coverage may underlie age-related reductions in neurovascular coupling. The extent to which cortical blood vessels are contacted by pericyte processes was assessed using co-localisation analysis of PDGFR-β, as a marker of pericytes, with collagen IV-labelled vessels. As predicted, aged mice displayed significantly reduced vascular pericyte coverage compared to young mice (F(1,29)= 10.21, p<0.01) but there were no significant genotype or interaction effects (Fig 5). Furthermore, vascular pericyte coverage was unrelated to the extent of neurovascular coupling (r=0.28; p>0.05).
In the thalamus, vascular pericyte coverage analysis revealed a significant age effect (F(1,29)= 13.05, p<0.01) with aged mice displaying reduced vascular pericyte coverage compared to young, but there was no effect of genotype (Supplementary Fig 4).

3.6 Reduced coverage of cortical blood vessels by astrocytic endfeet AQP4 in aged mice
Neurovascular coupling is suggested to be mediated, in part, by contact between astrocytic endfeet and cerebral blood vessels (Bazargani and Attwell, 2016). To investigate whether alterations in neurovascular unit structure might underlie impairments in vascular function, the integrity of this contact was assessed using aquaporin-4 as a marker of astrocytic endfeet and the extent co-localised to vessels determined. Significant effects of age and genotype were detected, with aged mice displaying a significant reduction in astrocytic end-feet expression of AQP4 on blood vessels compared to young mice (F(1,29)= 27.85, p<0.0001), and greater vascular AQP4 coverage in TgSwDI compared to wild type mice (F(1,29)= 13.41, p=0.001) (Fig 6). Interestingly, there was a significant positive correlation between neurovascular coupling and AQP4 localisation on cortical blood vessels (r=0.45, p=0.01). There was a trend toward an increase in parenchymal expression of AQP4 in aged transgenic mice, however this did not reach statistical significance (F(1,29)= 4.2, p=0.05) (data not shown or supplementary??). Having identified alterations in the contact between astrocytes and blood vessels, we also sought to determine if the number of GFAP+ve astrocytes was altered with age or amyloid deposition. Analysis of GFAP-positive astrocytes revealed significant effects of age and genotype (F(1,29)= 36.78, p<0.0001 and F(1,29)= 27.14, p<0.0001 respectively) and also a significant interaction effect (F(1,29)= 28.27, p<0.0001) (Fig 7). Aged TgSwDI mice had a significantly greater number of GFAP+ve astrocytes compared to aged wild type mice (p<0.001).

The reduction with age in astrocytic end-feet expression of AQP4 on blood vessels was also found in the thalamus (F(1,29)= 33.78, p<0.0001), however there was no genotype effect (Supplementary Fig 5). Additionally, a more pronounced increase in parenchymal AQP4 expression in TgSwDI mice was noted. Analysis of parenchymal AQP4 expression revealed significant effects of age and genotype (F(1,29)= 78.24, p<0.0001 and F(1,29)= 27.81, p<0.0001 respectively) as well as a significant interaction effect (F(1,29)= 45.07, p<0.0001), whereby aged TgSwDI mice displayed a significant increase in parenchymal AQP4 compared to aged wild type mice (p<0.001). Similarly to cortical measures, there were significant effects of age and genotype on number of GFAP+ve astrocytes in the thalamus (F(1,29)= 339.8, p<0.0001 and F(1,29)= 184.2, p<0.0001 respectively) and also a significant interaction effect (F(1,29)= 168.6, p<0.0001) (Supplementary Fig 6). Aged TgSwDI mice had significantly more GFAP-positive astrocytes compared to aged wild type mice (p<0.001).

3.7 Microglial activation/number is increased with ageing and exacerbated in TgSwDI mice
Following on from the demonstration that alterations in GFAP+ve astrocytes are associated with reduced vascular function, we sought to identify whether microglial activation may also be related to changes in neurovascular coupling. Quantification of Iba1-positive microglia performed in the barrel cortex in adjacent sections to those used to identify astrocytic end feet processes. Significant effects of age and genotype were detected, with significantly more Iba1-positive microglia in aged mice compared to young (F(1,29)= 17.97, p<0.001), and in TgSwDI mice compared to wild type (F(1,29)= 13.88, p<0.001) (Fig 8). Post-hoc tests revealed significantly more Iba1-positive microglia in aged TgSwDI compared to aged wild type (p<0.01). Further, the number of Iba1+ve microglia correlated significantly with the extent of neurovascular coupling (r= -0.55, p<0.01).
In the thalamus, quantification of Iba1-positive microglia revealed significant effects of age and genotype (F(1,29)= 133.9, p<0.0001 and F(1,29)= 82.57, p<0.0001 respectively) and also a significant interaction effect (F(1,29)= 48.09, p<0.0001) (Supplementary Fig 7). Iba-1+ve microglia were significantly increased in aged TgSwDI mice compared to aged wild type mice (p<0.001). 


3.8 p47 subunit of NADPH oxidase 2 is increased with ageing
To further probe the mechanisms by which age may contribute to impaired neurovascular coupling we quantified immunostaining for p47, a subunit of the NADPH oxidase 2 (NOX2). This is a major contributor to reactive oxygen species, is highly expressed by glia (Bedard and Krause, 2007) and is also highly activated in response to amyloid (Han et al. 2015).  In the cortex, there was a significant increase in NOX2 with age (F(1,29)= 6.906, p<0.05) but no effect of genotype and no interaction (Fig 9). Further there was no significant association between the extent of p47 staining and neurovascular coupling.
In the thalamus, there were significant effects of age and genotype (F(1,29)= 39.71, p<0.001 and F(1,29)= 19.4, p<0.001) respectively) and also a significant interaction effect (F(1,29)= 12.7, p<0.01) (Supplementary Fig 8). Aged TgSwDI mice had significantly increased p47 expression compared to aged wild type mice (p<0.001) consistent with more pronounced amyloid deposition in this brain region.


4. Discussion
The current study demonstrates that neurovascular coupling, in the cortex, is progressively impaired with advancing age and that these changes are closely related to disruption of astrocytic end feet contact on vessels and increased gliosis.  However, contrary to the original predictions, the presence of extensive cortical amyloid deposition did not exacerbate the alterations in neurovascular unit function or structure.
Neurovascular coupling is impaired with age
Age-related impairments in neurovascular coupling in wild type mice were apparent at 12 months of age and further impaired at 24 months of age. The extent of reduction in blood flow responses to whisker stimulation was marked and decreased by approximately 33% from 6 to 12 months of age. This data is in keeping with previously published work (Park et al. 2007), however another study has also shown that the cerebral vasculature may become impaired as early as 8 months of age (Balbi et al. 2015) when comparing blood flow responses to 6 week old mice. Several clinical imaging studies have also demonstrated that increased age is related to reduced vascular responsiveness (Hutchison et al. 2013; Gauthier et al. 2013; Mohtasib et al. 2012). These differences have been reported in groups with an average age of 60 years, although it is not yet known when vascular functional impairments are first evident and there are likely to be differences between brain regions. In the present study, impairments in neurovascular coupling were not accompanied by changes in resting cortical blood flow or cortical vessel density. Reductions in cerebral blood flow with age have been reported in both human and mouse imaging studies (Chen et al. 2011; Hébert et al. 2013). The lack of change in resting blood flow to the barrel cortex in the present study may be attributed to the relative insensitivity of measuring from such a small area, and an alternative approach may be required in future to assess whether age-related vascular dysfunction also extends to resting cerebral blood flow. Matching neuronal activity to changes in blood flow via neurovascular coupling is essential to prevent hypoxia and preserve neuronal function. Reduced vascular function is associated with cognitive impairment and even conversion from MCI to Alzheimer’s disease (Viticchi et al. 2012; Mohtasib et al. 2012). Improving or preserving vascular function in mid to old age may therefore prove an effective, early timepoint for therapeutic intervention, prior to the onset of diseases that affect cognition such as Alzheimer’s disease and Vascular Dementia.
Neurovascular coupling was not further impaired in the presence of cortical amyloid
Although our data demonstrated prominent age-related impairments in 12 and 24 month old mice , despite the presence of extensive cortical amyloid deposition  in TgSwDI these mice were no more impaired on measures of neurovascular coupling than their wild type littermates. This was an unexpected finding since amyloid has been shown to have profound effects on vascular function (Dumas et al. 2012; Niwa et al. 2002). Further to this, previous work in transgenic mice that develop age-related amyloid deposition has also shown that neurovascular coupling is impaired relative to mice that do not develop amyloid pathology (Park et al. 2005, 2008). These discrepancies may be partly explained by differences in the particular amyloid species present in the models at the time of measurement of neurovascular coupling and the extent of vascular amyloid. In TgSwDI mice, soluble, oligomeric amyloid levels are low and since oligomeric rather than fibrillar amyloid can have direct effects on vascular health (Park et al. 2005) there may, arguably, have been minimal impact of this amyloid species on cortical blood flow responses in the TgSwDI mice. However, using the same TgSwDI line, work published by Park et al. (2014) has shown blunted responses to whisker stimulation at just 3 months of age, prior to the accumulation of any amyloid deposition. The authors attribute this impairment to the presence of soluble amyloid, although this is not measured directly. It is possible that this early impairment was not detected in our study due to differences in experimental design, for instance the use of laser speckle imaging rather than laser Doppler and a cranial window, however further work to investigate the contribution of soluble amyloid to vascular dysfunction in this model may be required. More recently, Kimbrough et al. (2015) used in vivo multiphoton imaging to elegantly demonstrate that in hAPPJ20 mice, neurovascular function was only impaired where there was evidence of vascular amyloid. Within the same vessel, segments in which there was an absence of vascular amyloid displayed vascular responses that were comparable to wild type mice. In the present study, the coverage of vessels by amyloid was low and at most was 2.7% of the vascular surface in the cortex. Thus, the present study’s use of laser speckle flowmetry, a gross measure of cortical blood flow responses, may be a relatively insensitive method to detect localised alterations in blood flow (Ayata et al. 2004). It is worth noting that the TgSwDI model does develop extensive microvascular amyloid deposition in the thalamus. Assessing vascular reactivity in this region, for example utilising ASL with a hypercapnic challenge, may yield further information about whether vascular amyloid exerts a detrimental effect on vascular function. 
Contribution of pericytes to neurovascular coupling
In order to determine the potential mechanisms that may contribute to impairments in neurovascular coupling, alterations in components of the neurovascular unit were examined at 6 and 24 months of age, ages at which neurovascular coupling was normal and profoundly impaired, respectively. Since pericytes have been suggested to regulate cerebral blood flow, particularly at the capillary level (Hall et al. 2014), we investigated the vascular coverage of pericytes as a potential mechanism by which neurovascular coupling may be impaired.  In support of this we found a pronounced reduction of the coverage of vessels with pericytes in aged brain as compared to young. Similar to the lack of differences in neurovascular coupling between TgSwDI and wild-type mice, there were no genotype differences in pericyte coverage. Previous studies have similarly shown a reduction of pericyte coverage in the frontal cortex and hippocampus of aged mice (Soto et al. 2015; Tucsek et al. 2014), suggesting that pericytes in multiple brain regions may be vulnerable to age-related degeneration. Pericytes are suggested to regulate cerebral blood flow at the capillary level (Hall et al. 2014), however the extent to which they are able to contract and relax to modulate vascular diameter has recently come under scrutiny (Hill et al. 2015). In the present study, we were able to assess vascular response to whisker stimulation in order to investigate links between vessel function and pericyte/vessel contact. However, we did not find any correlation between vessel function and cortical vascular pericyte coverage. In agreement with this finding, Balbi et al. (2015) finds no reduction in pericyte number at 12 months of age, despite a pronounced impairment in vascular function. However, pericyte loss may primarily effect the function of small-calibre vessels i.e. capillaries, which may be less important when compared to arterioles or other larger vessels in controlling blood flow responses to whisker stimulation. The contribution of distinct vessel populations to perfusion was not assessed in this study, so we cannot rule out a role for pericyte loss in contributing to age-related vascular dysfunction. Loss of pericyte coverage may also indirectly lead to impaired vessel function through increased permeability of the blood-brain barrier (Montagne et al. 2015), infiltration of circulating neutrophils and enhanced neuroinflammation.
Contact between astrocytes and blood vessels may be critical for normal neurovascular coupling
Astrocytes and their endfeet are known to have critical roles in regulating cerebral blood flow (Bazargani and Attwell, 2015), so we investigated whether alterations in the contact between astrocytes and blood vessels may be related to impairments in neurovascular coupling. In aged 24 month old mice there was a profound loss of vascular localisation of AQP4 labelling of astrocytic endfeet contacts in the cerebral cortex and thalamus, whereas 6 month old mice demonstrated extensive colocalisation between blood vessels and AQP4. Furthermore a highly significant relationship between AQP4 and neurovascular coupling was determined. AQP4 is expressed in astrocytes and is typically polarised to the perivascular endfoot. Loss of vascular AQP4 localisation may therefore indicate disruption of the contact between vessels and astrocytes, a site that is thought to be critical for neurovascular coupling. We also observed an age-related increase in the number of GFAP+ve astrocytes, suggestive of an increase in astrocytic activation. Process retraction following activation may contribute to the disruption of astrocyte/vessel contact. Neuronal activity elicits intracellular calcium increases in the soma of astrocytes (Bazargani and Attwell, 2016), which in turn results in the release of arachidonic acid-derived vasodilators such as prostaglandins and epoxyeicosatrienoic acids (EETs) from the astrocyte endfoot. Disruption of contact between astrocytic endfeet and vasculature, as reflected in loss of vascular AQP4 coverage, may result in loss of this vasodilatory input and lead to impairments in neurovascular coupling. Our findings are in line with those of Kress et al (2014), who previously showed reductions in vascular AQP4 expression on penetrating arterioles, but not on cortical capillaries, in 18 month old wild type mice compared to 2-3 month old mice. Although different vessel populations were not assessed in the current study, the more advanced age of the mice is likely to have resulted in greater reductions in vascular AQP4. In the present study, we demonstrate a clear relationship between AQP4 localisation on vessels and neurovascular coupling. The work of Kress et al. (2014) demonstrates that a loss of AQP4 localisation on cerebral blood vessels is associated with impaired function of the glymphatic pathway, driven by reductions in cerebrovascular pulsation. Together, the data suggest a critical role for expression of AQP4 on cerebral vasculature in order to maintain normal vascular function. Age-related loss of vascular AQP4 may predispose to vascular dysfunction and cognitive decline. Indeed, AQP4 expression has been shown to be reduced in Alzheimer’s disease brain (Wilcock et al. 2009) and loss of vascular AQP4 has recently been shown to occur in post-stroke dementia (Chen et al. 2016).
Microglial activation is associated with reduced neurovascular coupling
Neuroinflammation is reported to be increased in the ageing brain (Luo, Ding and Chen, 2010) and in response to amyloid (for review see Heneka et al. 2015). In the present study, we quantified Iba1+ve microglia in order to investigate whether neuroinflammatory processes may also contribute to impaired neurovascular coupling. We observed an increase in cortical microglial activation in aged mice relative to young, and this increase was further exacerbated in the presence of amyloid. We were also able to show a relationship between microglial activation and measures of neurovascular coupling. One proposed mechanism through neurovascular coupling may become disrupted is through the increased production of reactive oxygen species (Park et al. 2008). Activation of microglia increases the activity of the superoxide-generating NADPH oxidase complex (Gao, Zhou and Hong, 2012). In line with this data, we observed an increase in expression of the p47 subunit of NADPH oxidase 2 in aged mice compared to young. Interestingly, this increase was not further exacerbated in the cortex of TgSwDI mice relative to wild type but was increased in the thalamus, suggesting that the greater levels of amyloid in this region results in much greater activation of the NADPH oxidase complex. Reactive superoxide species, produced by NADPH oxidase complexes, are able to form peroxynitrite, which in turn is able to inhibit the formation of vasodilators such as prostaglandins (Zou, 2007) and EETs (Barbosa-Sicard et al. 2009). Persistent oxidative stress also inhibits the activity of endothelial nitric oxide synthase (Arunachalam et al. 2010) resulting in reduced bioavailability of nitric oxide in the endothelium. Combined, these changes may significantly impair the vasodilatory capacity of the cerebral blood vessels. We did not find any correlation between neurovascular coupling responses and the amount of cortical p47 staining, however, direct quantification of superoxide production would shed further light on whether this contributes to impaired neurovascular function.

Conclusion
Normal ageing leads to profound neurovascular unit dysfunction which is not further impaired with increased amyloid burden. Vascular dysfunction can cause hypoperfusion or localised hypoxia, leading to neurodegeneration and cognitive decline. Therefore targeting vascular health as individuals age could prove an effective strategy to reduce cognitive decline and delay the onset of dementia.
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